Related Articles
Clinical analysis of metaplastic breast carcinoma with distant metastases: A multi‑centre experience
p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer
P(185/HER2) AND PS2 PROTEIN OVEREXPRESSION IN BREAST-CANCER SPECIMENS - IMPROVEMENT FOR PREDICTION OF RESPONSE TO ENDOCRINE THERAPY
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer
Effect of HER2 expression status on the prognosis of patients with HR<sup>+</sup>/HER2<sup>‑</sup> advanced breast cancer undergoing advanced first‑line endocrine therapy